Press Releases - 2022-01-10

Date	Title	Company
10-Jan-2022	Magenta Therapeutics Highlights Recent Pipeline Progress and Milestone Expectations for 2022	Businesswire
10-Jan-2022	Sesen Bio Further Enhances Team with Key Hires	Businesswire
10-Jan-2022	ArsenalBio Announces Expansion of Collaboration with Bristol Myers Squibb to Advance T Cell Therapy in Solid Tumors	Businesswire
10-Jan-2022	Tenaya Therapeutics Provides 2022 Business Updates	Businesswire
10-Jan-2022	JAMP and Alvotech Announce Canadian Approval of SIMLANDI™, a High-Concentration Biosimilar to Humira®, Providing Access to Previously Unavailable Versions in Canada	Businesswire
10-Jan-2022	Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones	Businesswire
10-Jan-2022	DEFENCE THERAPEUTICS ACHIEVES A MAJOR MILESTONE AND BEGINS IND-ENABLING TESTING OF ITS ACCUTOX LEAD COMPOUND AGAINST BREAST CANCER	Defence Therapeutics Inc.
10-Jan-2022	Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results	Businesswire
10-Jan-2022	NervGen Pharma Announces Intent to Conduct Groundbreaking Spinal Cord Injury Clinical Trial in Exclusive Partnership With Shirley Ryan AbilityLab, #1-Ranked Hospital in Physical Medicine & Rehabilitation	Businesswire
10-Jan-2022	Pyramid Biosciences Appoints Brian Lestini, MD, PhD as Chief Executive Officer	Businesswire
10-Jan-2022	Can-Fite to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference	Businesswire
10-Jan-2022	Inogen Announces Preliminary, Unaudited Full Year and Fourth Quarter 2021 Revenue Results	Businesswire
10-Jan-2022	Acadia Pharmaceuticals and Stoke Therapeutics Announce Collaboration to Pursue Multiple RNA-based Treatments for Severe and Rare Genetic Neurodevelopmental Diseases	Businesswire
10-Jan-2022	VitalConnect Announces Closure of $39 Million Round of Growth Financing	Businesswire
10-Jan-2022	Puma Biotechnology Releases Updated Corporate Presentation	Businesswire
10-Jan-2022	Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full Year 2021 Financials and Clinical Trial Updates	Businesswire
10-Jan-2022	Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors	Businesswire
10-Jan-2022	Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies	Businesswire
10-Jan-2022	NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms	Businesswire
10-Jan-2022	Two Day Online Clinical Trial Regulatory Requirements Training Course (January 27-28, 2022) - ResearchAndMarkets.com	Businesswire